Phase I study of pazopanib (PAZ) in combination with PCI-24781 (PCI) in patients (pts) with metastatic solid tumors with new tumor proliferation imaging correlates in renal cell carcinoma (RCC) and sarcoma.
Thach-Giao Truong
No relevant relationships to disclose
Jennifer A. Grabowsky
No relevant relationships to disclose
Stephanie Chen
No relevant relationships to disclose
Roth Ea
No relevant relationships to disclose
Andrew H. Ko
No relevant relationships to disclose
Terence W. Friedlander
No relevant relationships to disclose
Emily K. Bergsland
No relevant relationships to disclose
Andrea Lynne Harzstark
No relevant relationships to disclose
Anne Reinert
No relevant relationships to disclose
Gordon Fung
No relevant relationships to disclose
Adil Daud
Research Funding - GlaxoSmithKline (I); Pharmacyclics (I)
Pamela N. Munster
Research Funding - GlaxoSmithKline; Pharmacyclics